Clinical Trial

Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction

Name: Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction — clinical trial record (NCT07611838)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To develop and externally validate a machine learning model for predicting the 1-year risk of relapse in patients with stable ABPA, and to further evaluate its value in risk stratification and clinical decision-making.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-21.

Trial Details

NCT Number	NCT07611838
Lead Sponsor	Qianfoshan Hospital
Conditions	Allergic Bronchopulmonary Aspergillosis (ABPA), Machine Learning, Multi-omics, Multicenter Study, Relapse
Enrollment	300 participants
Start Date	2021-01-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-01